Emerging pharmacotherapies and regenerative solutions for promoting hair growth for androgenetic alopecia - PubMed
10 hours ago
- #androgenetic alopecia
- #regenerative medicine
- #hair regrowth
- Traditional treatments like minoxidil and finasteride for androgenetic alopecia (AGA) have limitations, leading to a need for novel therapies.
- Emerging pharmacotherapies include targeted androgen receptor modulators (e.g., pyrilutamide) that avoid systemic hormonal effects.
- Regenerative approaches, such as exosomes and mesenchymal stromal cell-conditioned media, activate dermal papilla cells and improve hair density.
- Peptide-based formulations and growth-factor concentrates show anabolic effects on hair follicles.
- Platelet-rich plasma (PRP) is widely studied and may enhance results when combined with traditional treatments.
- Current research faces challenges due to variability in study designs and protocols, requiring more standardized trials.
- Future directions involve combination strategies and mechanistic studies to develop effective, long-lasting treatments for AGA.